samir pandit

You Can’t Optimize Your Way Out of Biology

Written by

Samir Pandit

in

What we’re trying to do

The modern longevity movement is driven by a very understandable instinct. If we can measure what matters inside the body, keep those measurements in acceptable ranges, and steadily improve them over time, then a longer life should follow. That belief explains the attention paid to cholesterol panels, blood sugar, inflammatory markers, biological age scores, fitness numbers, and even gut bacteria profiles.

The reasoning feels obvious: if a number is associated with death, then improving that number ought to reduce the risk.

It sounds disciplined. It sounds evidence-based.
But it rests on a faulty assumption about how living systems behave.

This mistake isn’t new. It is the same conceptual error that shaped decades of nutrition advice and eventually gave us the original food pyramid.

The core error

Both longevity biohacking and dietary pyramids make the same leap: they treat population-level risk markers as if they were individual-level control dials.

Large datasets reveal correlations. Those correlations get translated into rules. The rules are applied to individuals. From there, it’s quietly assumed that following the rule must produce the desired outcome. When lab values improve, confidence grows. When confidence grows, the framework appears to work. Meanwhile, real outcomes remain inconsistent, slow, or absent.

Over time, improving numbers starts to feel like progress even when health and longevity barely move.

What biomarkers actually do

Biomarkers are useful, but not in the way they’re often marketed. They function best as warning lights. They highlight elevated risk and point to systems under strain. They do not tell you how long you will live, and they do not provide a reliable method for extending the upper limits of human lifespan.

Medicine learned this lesson the hard way in the late twentieth century, after repeated attempts to improve surrogate markers failed to improve survival and sometimes caused harm. Longevity culture is now relearning the same lesson, only with cleaner dashboards, better sensors, and more persuasive charts.

The biomarkers people focus on and what the evidence actually shows

1. LDL / ApoB (cholesterol)

Idea
LDL contributes to plaque formation. Lower LDL reduces heart attacks. Therefore, very low LDL should mean a longer life.

Reality
Lowering LDL reliably reduces cardiovascular events, but does not reliably extend maximum human lifespan. In older adults, very low LDL is sometimes associated with higher all-cause mortality due to frailty, cancer, or reverse causation.

Evidence
Randomized trials show fewer heart attacks with LDL lowering, but no clear extension of maximum lifespan and inconsistent effects on all-cause mortality.

Verdict
LDL prevents one failure mode. It does not control longevity.

2. HbA1c (average blood sugar)

Idea
High blood sugar damages organs. Lowering HbA1c must slow aging.

Reality
Very high HbA1c is harmful. But aggressively forcing HbA1c into the “ideal” range increased mortality due to hypoglycemia and systemic stress.

Evidence
Intensive glucose-lowering improved HbA1c while increasing death rates in large randomized trials.

Verdict
Correct extremes save lives. Over-optimization can kill.

3. Insulin/insulin resistance

Idea
Insulin resistance predicts diabetes. Lower insulin signaling should improve longevity.

Reality
Suppressing insulin signaling improves metabolic markers but weakens muscle, bone, immune function, and recovery, with no proven lifespan benefit in humans.

Evidence
Human calorie-restriction studies improve insulin markers without demonstrating extended lifespan.

Verdict
Metabolic neatness is not biological robustness.

4. Inflammation markers (CRP, IL-6)

Idea
Aging equals inflammation. Suppressing inflammation and aging slows.

Reality
Inflammation also enables repair and immune defense. Broad suppression reduces some disease events while increasing infection risk and failing to reduce overall mortality.

Evidence
Targeted anti-inflammatory therapy reduced cardiovascular events but did not reduce all-cause mortality and increased fatal infections.

Verdict
Inflammation is controlled fire, not rust.

5. Epigenetic clocks (biological age)

Idea
If biological age goes down, aging has been reversed.

Reality
Epigenetic clocks are population-level predictors that disagree with each other and can improve without improving function or survival.

Evidence
No study shows that improving an epigenetic clock extends human lifespan or causally alters aging.

Verdict
A map describes risk. It does not drive aging.

6. VO₂ max (cardiorespiratory fitness)

Idea
Higher VO₂ max equals longer life.

Reality
Moving from low to moderate fitness dramatically reduces mortality risk, while gains beyond that show diminishing returns and added risk.

Evidence
Cohort studies show a strong survival benefit from avoiding low fitness, not unlimited gains from maximal fitness.

Verdict
Avoid being unfit. Extremes are optional.

7. Grip strength

Idea
Grip strength predicts survival. Increasing it must extend life.

Reality
Grip strength reflects frailty and disease burden. Improving grip strength alone has not been shown to extend lifespan.

Evidence
Grip strength predicts mortality as a proxy for health, not as a causal driver.

Verdict
A signal, not a cause.

8. IGF-1 / mTOR suppression

Idea
Suppress growth pathways as in animals and live longer.

Reality
In humans, low IGF-1 is linked to frailty, muscle loss, and cognitive decline, with no proven lifespan extension.

Evidence
Human data show trade-offs from growth suppression without demonstrated survival benefit.

Verdict
Animal results do not scale cleanly to humans.

9. Telomere length

Idea
Short telomeres mean faster aging.

Reality
Telomere length correlates with mortality on average, but measurements are noisy, and interventions have not extended lifespan.

Evidence
Associations exist, but telomere length has not proven to be a controllable longevity lever.

Verdict
Correlation without command.

10. Gut microbiome

Idea
Fix gut bacteria, and longevity follows.

Reality
Distinct microbiome patterns are observed in long-lived people, but causality and lifespan extension in humans remain unproven.

Evidence
Human microbiome interventions change composition and biomarkers without demonstrated survival benefit.

Verdict
Promising science, not a lever yet.

The food pyramid: then and now

What the old food pyramid got wrong

The original food pyramid grew out of correlations: saturated fat with heart disease, cholesterol with plaque, and calories with weight. Over time, those correlations hardened into rules. Fat was minimized. Carbohydrates became foundational. Ultra-processed foods quietly filled the gap.

Some markers improved. Population health did not.

The pyramid optimized numbers, not metabolism.

The new food-pyramid thinking: what actually changed

To its credit, nutrition science noticed the failure.

A newer generation of dietary guidance visuals has emerged. It is less rigid than the 1990s pyramid, less simplistic than MyPlate, and far more explicit about reducing ultra-processed foods. Compared to the old grain-heavy model, several genuine corrections stand out.

Ultra-processed foods are no longer treated as neutral calories. Refined carbohydrates, added sugars, and industrial food products are now clearly implicated in obesity and metabolic disease.

Fat and protein are no longer automatic villains. The reflexive low-fat by default stance has softened, and whole-food sources of fat, which are nuts, eggs, dairy, meat, and fish, are no longer pushed to the margins.

There is also more emphasis on food quality rather than macronutrient arithmetic. Eat real food appears more often than hit these ratios. Protein, particularly for aging populations, is given greater importance for preserving muscle and function.

These changes matter. They reflect better evidence and a willingness to admit past errors.

What still didn’t change

Despite improved language and better targets, the underlying logic remains intact.

The new pyramid still turns population averages into templates, implies that compliance produces outcomes, struggles with individual metabolic diversity, ignores age-dependent trade-offs, and frames health as obedience rather than adaptation.

The diagram improved.
The assumption did not.

Better guidance does not fix a bad abstraction.

This is the same mistake longevity biohacking now makes with biomarkers.

What biomarkers are actually good for and where to stop

Used properly, biomarkers are valuable guardrails. They help with early detection, risk stratification, treatment thresholds, and identifying meaningful deviations from personal baselines. In those roles, they save lives.

They fail when treated as design targets for life itself.

A simple boundary holds: use biomarkers to detect problems, not to define perfection.

Longevity without dashboards

When the numbers fade into the background, longevity still leaves patterns behind. Long-lived people tend to maintain functional movement rather than maximal performance, enough strength to resist frailty, metabolic flexibility rather than chronic suppression, durable social ties, and a sense of direction that pulls them forward. They leave slack in the system with room to rest, recover, and adapt.

These traits rarely appear cleanly in lab panels, yet they shape survival more reliably than pristine dashboards.

Longevity emerges from robustness, not precision.

Conclusion

Biomarkers are tools, not truths. They help avoid obvious failure, but they cannot design a long life. The old food pyramid failed by optimizing markers instead of metabolism. The new one fixes some villains but keeps the same logic. Longevity biohacking risks repeating the error with blood tests instead of food groups.

Biomarkers are headlights.
The food pyramid is a map.
Longevity is the terrain.

Confusing indicators with control is how smart people keep making the same mistake, and only now with better graphics.

References